Truist Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$450K	Buy	36,235 +10,627	+41%	+$143K	﹤0.01%	2133
2025 Q4	$323K	Buy	25,608 +11,944	+87%	+$137K	﹤0.01%	2283
2025 Q3	$137K	Buy	+13,664	New	+$123K	﹤0.01%	2605
2024 Q2	–	Sell	-65,130	Closed	-$395K	–	2644
2024 Q1	$395K	Hold	65,130	–	–	﹤0.01%	2130
2023 Q4	$395K	Buy	+65,130	New	+$290K	﹤0.01%	2131
2022 Q4	–	Sell	-24,896	Closed	-$50K	–	2559
2022 Q3	$50K	Sell	24,896 -35,948	-59%	-$101K	﹤0.01%	2468
2022 Q2	$193K	Hold	60,844	–	–	﹤0.01%	2454
2022 Q1	$254K	Hold	60,844	–	–	﹤0.01%	2413
2021 Q4	$291K	Hold	60,844	–	–	﹤0.01%	2384
2021 Q3	$325K	Sell	60,844 -14,541	-19%	-$73.2K	﹤0.01%	2288
2021 Q2	$386K	Buy	+75,385	New	+$428K	﹤0.01%	2225
2020 Q4	–	Sell	-10,000	Closed	-$39K	–	2543
2020 Q3	$39K	Hold	10,000	–	–	﹤0.01%	2400
2020 Q2	$48K	Hold	10,000	–	–	﹤0.01%	2337
2020 Q1	$35K	Sell	10,000 -83	-0.8%	-$352	﹤0.01%	2316
2019 Q4	$49K	Buy	+10,083	New	+$35K	﹤0.01%	2443